Associated Papers
Alectinib efficacy in advanced lung adenocarcinoma with coexistence of a novel ALK-MTUS2 and STRN3-ALK double fusion: A case report and literature review.
Qiu X et al.
Oncology Letters, 2025
Mixed responses to first-line alectinib in non-small cell lung cancer patients with rare ALK gene fusions: A case series and literature review.
Li M et al.
Journal of Cellular and Molecular Medicine, 2021
STRN-ALK Fusion in Lung Adenocarcinoma with Excellent Response Upon Alectinib Treatment: A Case Report and Literature Review.
Su C et al.
Oncotargets and Therapy, 2020
Select a paper to view details